Friday, 31 July 2026 · World
USD/EUR 0.8688 USD/GBP 0.7446 USD/JPY 160.6 USD/CNY 6.766 All rates →
RSS
EUROS The World Financial Report
Nº 20 Friday, 31 July 2026 · World Edition
LATEST
Markets

J&J’s biotech progress could punish its 2027 profit

TST (Full) - (Official Feed) · 1h ago
J&J’s biotech progress could punish its 2027 profit

Johnson & Johnson (JNJ) just issued one of the weirdest profit warnings in health care. The biotech business decreased its 2026 adjusted earnings guidance to between $10.96 and $11.11 a share, from a range of $11.60 to $11.75. This year, the newly closed acquisition of Firefly Bio and the ...

Read the full story at TST (Full) - (Official Feed) →